- Home
- FUTU vs HUMAW Comparison
FUTU vs HUMAW Comparison
Compare FUTU & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUTU
- HUMAW
- Stock Information
- Founded
- FUTU 2011
- HUMAW 2004
- Country
- FUTU Hong Kong
- HUMAW United States
- Employees
- FUTU N/A
- HUMAW 185
- Industry
- FUTU Investment Bankers/Brokers/Service
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- FUTU Finance
- HUMAW Health Care
- Exchange
- FUTU Nasdaq
- HUMAW Nasdaq
- Market Cap
- FUTU N/A
- HUMAW N/A
- IPO Year
- FUTU 2019
- HUMAW N/A
- Fundamental
- Price
- FUTU $79.65
- HUMAW $0.40
- Analyst Decision
- FUTU Strong Buy
- HUMAW
- Analyst Count
- FUTU 4
- HUMAW 0
- Target Price
- FUTU $122.75
- HUMAW N/A
- AVG Volume (30 Days)
- FUTU 3.6M
- HUMAW 14.2K
- Earning Date
- FUTU 05-27-2025
- HUMAW 03-21-2025
- Dividend Yield
- FUTU 2.42%
- HUMAW N/A
- EPS Growth
- FUTU 27.23
- HUMAW N/A
- EPS
- FUTU 5.01
- HUMAW N/A
- Revenue
- FUTU $1,541,380,749.00
- HUMAW N/A
- Revenue This Year
- FUTU $41.70
- HUMAW N/A
- Revenue Next Year
- FUTU $11.69
- HUMAW N/A
- P/E Ratio
- FUTU $15.91
- HUMAW N/A
- Revenue Growth
- FUTU 31.60
- HUMAW N/A
- 52 Week Low
- FUTU $51.80
- HUMAW $1.18
- 52 Week High
- FUTU $130.88
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- FUTU 36.44
- HUMAW N/A
- Support Level
- FUTU $70.60
- HUMAW N/A
- Resistance Level
- FUTU $89.37
- HUMAW N/A
- Average True Range (ATR)
- FUTU 6.11
- HUMAW 0.00
- MACD
- FUTU -0.90
- HUMAW 0.00
- Stochastic Oscillator
- FUTU 26.85
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.